InspireMD, Inc. Announces Annual Meeting of Stockholders
Ticker: NSPR · Form: DEF 14A · Filed: Apr 18, 2024 · CIK: 1433607
| Field | Detail |
|---|---|
| Company | Inspiremd, INC. (NSPR) |
| Form Type | DEF 14A |
| Filed Date | Apr 18, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: InspireMD, Annual Meeting, Proxy Statement, Stockholders, Corporate Governance
TL;DR
<b>InspireMD, Inc. is holding its annual stockholder meeting on June 10, 2024, and is utilizing internet delivery for proxy materials.</b>
AI Summary
InspireMD, Inc. (NSPR) filed a Proxy Statement (DEF 14A) with the SEC on April 18, 2024. InspireMD, Inc. will hold its annual meeting of stockholders on June 10, 2024, at 10:00 a.m. Eastern Time. The meeting will take place at InspireMD, Inc.'s offices located at 4 Menorat Hamaor St., Tel-Aviv, Israel. Stockholders are encouraged to RSVP by May 31, 2024, to craigs@inspiremd.com or +972-3-6917691 for meeting admission. Proxy materials will be delivered over the Internet, with a Notice of Internet Availability sent on or about April 18, 2024. Stockholders can vote by telephone, over the Internet, or by returning a proxy card.
Why It Matters
For investors and stakeholders tracking InspireMD, Inc., this filing contains several important signals. The company is providing notice of its annual meeting, which is a standard corporate governance event for public companies. The use of internet delivery for proxy materials aims to reduce costs and conserve resources, a common practice for public companies.
Risk Assessment
Risk Level: low — InspireMD, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational information that would indicate significant risk.
Analyst Insight
Stockholders should review the proxy materials and vote their shares for the upcoming annual meeting.
Key Numbers
- June 10, 2024 — Annual Meeting Date (Date of the annual meeting of stockholders)
- 10:00 a.m. Eastern Time — Annual Meeting Time (Time of the annual meeting of stockholders)
- May 31, 2024 — RSVP Deadline (Deadline to advise attendance plans)
- April 18, 2024 — Proxy Material Notice Date (Date proxy materials will be sent via internet)
Key Players & Entities
- InspireMD, Inc. (company) — Registrant
- Craig Shore (person) — Contact for meeting attendance
- Saguaro Resources, Inc. (company) — Former company name
FAQ
When did InspireMD, Inc. file this DEF 14A?
InspireMD, Inc. filed this Proxy Statement (DEF 14A) with the SEC on April 18, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by InspireMD, Inc. (NSPR).
Where can I read the original DEF 14A filing from InspireMD, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by InspireMD, Inc..
What are the key takeaways from InspireMD, Inc.'s DEF 14A?
InspireMD, Inc. filed this DEF 14A on April 18, 2024. Key takeaways: InspireMD, Inc. will hold its annual meeting of stockholders on June 10, 2024, at 10:00 a.m. Eastern Time.. The meeting will take place at InspireMD, Inc.'s offices located at 4 Menorat Hamaor St., Tel-Aviv, Israel.. Stockholders are encouraged to RSVP by May 31, 2024, to craigs@inspiremd.com or +972-3-6917691 for meeting admission..
Is InspireMD, Inc. a risky investment based on this filing?
Based on this DEF 14A, InspireMD, Inc. presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational information that would indicate significant risk.
What should investors do after reading InspireMD, Inc.'s DEF 14A?
Stockholders should review the proxy materials and vote their shares for the upcoming annual meeting. The overall sentiment from this filing is neutral.
How does InspireMD, Inc. compare to its industry peers?
InspireMD, Inc. operates in the medical device industry, specifically focusing on cardiovascular interventions.
Are there regulatory concerns for InspireMD, Inc.?
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies.
Industry Context
InspireMD, Inc. operates in the medical device industry, specifically focusing on cardiovascular interventions.
Regulatory Implications
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies.
What Investors Should Do
- Review the proxy statement for details on matters to be voted on at the annual meeting.
- Vote your shares by telephone, internet, or mail to ensure your vote is counted.
- RSVP by May 31, 2024, if planning to attend the annual meeting in person.
Key Dates
- 2024-06-10: Annual Meeting of Stockholders — Key date for stockholder participation and voting.
- 2024-05-31: RSVP Deadline for Meeting Attendance — Ensures timely notification for building security access.
- 2024-04-18: Notice of Internet Availability of Proxy Materials Sent — Initiates the proxy voting process for stockholders.
Year-Over-Year Comparison
This filing is a Definitive Proxy Statement (DEF 14A) for the annual meeting, indicating a routine corporate governance event rather than a new financial disclosure.
Filing Stats: 4,774 words · 19 min read · ~16 pages · Grade level 12.9 · Accepted 2024-04-18 16:15:19
Key Financial Figures
- $0.0001 — consist of our common stock, par value $0.0001 per share. The accompanying proxy is
Filing Documents
- formdef14a.htm (DEF 14A) — 526KB
- formdef14a_001.jpg (GRAPHIC) — 2KB
- proxy_001.jpg (GRAPHIC) — 192KB
- proxy_002.jpg (GRAPHIC) — 157KB
- 0001493152-24-015191.txt ( ) — 1012KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 16 PROPOSAL 1: ELECTION OF CLASS 1 DIRECTORS 20 EXECUTIVE OFFICERS 24
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 25 PROPOSAL 2: ADVISORY VOTE ON EXECUTIVE COMPENSATION 37 PROPOSAL 3: ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTE ON EXECUTIVE COMPENSATION 37 PROPOSAL 4: RATIFICATION OF REAPPOINTMENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS, A MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED, AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 38 OTHER BUSINESS 39 SUBMISSION OF FUTURE STOCKHOLDER PROPOSALS 40 5 InspireMD, Inc. 4 Menorat Hamaor St. Tel Aviv, Israel 6744832 Telephone: (888) 776-6804 PROXY FOR ANNUAL MEETING OF STOCKHOLDERS To Be Held June 10, 2024 Unless the context otherwise requires, references in this Proxy Statement to “we,” “us,” “our,” the “Company,” or “InspireMD” refer to InspireMD, Inc., a Delaware corporation, and its direct and indirect subsidiaries. In addition, unless the context otherwise requires, references to “stockholders” are to the holders of our voting securities, which consist of our common stock, par value $0.0001 per share. The accompanying proxy is solicited by the board of directors on behalf of InspireMD, Inc., a Delaware corporation, to be voted at the annual meeting of stockholders of the Company (the “Annual Meeting”) to be held on June 10, 2024, at the time and place and for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders and at any adjournment(s) or postponement(s) of the Annual Meeting. The executive office of the Company is located at, and the mailing address of the Company is, 4 Menorat Hamaor St., Tel Aviv, Israel 6744832. IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL STOCKHOLDER MEETING TO BE HELD ON JUNE 10, 2024: Our Notice of Annual Meeting of Stockholders, Proxy Statement, Proxy Card and 2023 Annual Report to Stockholders are available at: www.proxyvote.com RE